2018
DOI: 10.1016/j.ab.2018.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Quantification of receptor activation by oxytocin and vasopressin in endocytosis-coupled bioluminescence reduction assay using nanoKAZ

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 43 publications
0
3
0
Order By: Relevance
“…nLuc-GLP-1R internalization is implicated by a decrease in luminescence due to the reduced availability of luciferase substrate inside the cell versus at the cell surface. 41 Luciferase substrate was introduced 30 min after addition of excess (1 µM) GLP-1 or peptides 1-7 . As expected, after GLP-1 treatment a substantial decline in luminescence was observed, which is consistent with extensive nLuc-GLP-1R internalization induced by the native hormone (Figures 2C, S3A).…”
Section: Resultsmentioning
confidence: 99%
“…nLuc-GLP-1R internalization is implicated by a decrease in luminescence due to the reduced availability of luciferase substrate inside the cell versus at the cell surface. 41 Luciferase substrate was introduced 30 min after addition of excess (1 µM) GLP-1 or peptides 1-7 . As expected, after GLP-1 treatment a substantial decline in luminescence was observed, which is consistent with extensive nLuc-GLP-1R internalization induced by the native hormone (Figures 2C, S3A).…”
Section: Resultsmentioning
confidence: 99%
“…While pre-treatment with 1 μM atosiban decreased the level of spontaneous contractility, secondary treatment with 1 nM analogs partially recovered contractility in the following order: HPOT > OT > FBOT. Thus, the ability of the analogs to counter the effects of atosiban did not match the potency or affinity orders as atosiban is known to be a non-selective antagonist acting via OT receptors and arginine vasopressin V1A or V1B receptors [ 36 ], one of the main differences between OT and its analogs may be selectivity for the V1A receptors [ 7 ]. HPOT was demonstrated to be more selective in the activation of OT receptors, especially at lower concentrations, while FBOT activated V1A receptors at higher concentrations [ 7 ].…”
Section: Discussionmentioning
confidence: 99%
“…Oxytocin-and vasopressin-activated receptors are coupled with G q/11 proteins and take part in regulating intracellular Ca 2+ contents and in activating protein kinase C [Kii et al, 2018]. In accordance with the modulation rules [Silkis, 2002], Avpr1b receptor agonists, like oxytocin, aid induction of LTP of the effi ciency of the synaptic inputs to PN in fi eld Ca 2+ , such that this NMDA-dependent LTP is linked Involvement of the Hypothalamic Nuclei [2014].…”
mentioning
confidence: 99%